TABLE 1

Clinical, hormonal, and metabolic features of women with PCOS and control subjects

VariablePCOSControl subjectsSignificance
n1010
Age (year)32.2 ± 5.832.7 ± 4.5NS
BMI (kg/m2)29.9 ± 2.329.2 ± 2.6NS
WHR0.87 ± 0.150.85 ± 0.16NS
Glucose (mmol/l)5.2 ± 0.74.6 ± 0.5P < 0.05
Insulin (pmol/l)90.9 ± 38.852.4 ± 15.0P < 0.05
HOMA3.5 ± 1.81.8 ± 0.6P < 0.01
Cholesterol (mmol/l)5.0 ± 0.85.2 ± 0.8NS
Fasting triglycerides (mmol/l)2.2 ± 1.21.0 ± 0.4P < 0.01
Leutinizing hormone (IU/l)8.6 ± 4.36.0 ± 4.2NS
Follicle-stimulating hormone (IU/l)6.3 ± 1.66.4 ± 2.7NS
Prolactin (mU/l)357.9 ± 87.9298.0 ± 85.8NS
E2(pmol/l)365.4 ± 101.0207.5 ± 67.8P < 0.01
Progesterone (nmol/l)1.9 ± 0.62.1 ± 0.4NS
17-OH-P (nmol/l)2.5 ± 0.71.9 ± 0.6NS
Testosterone (nmol/l)3.9 ± 1.12.4 ± 0.5P < 0.01
Androstenedione (nmol/l)13.0 ± 3.48.6 ± 2.3P < 0.01
DHEA-S (μmol/l)6.0 ± 1.34.7 ± 1.1NS
Sex hormone–binding globulin (nmol/l)31.6 ± 6.953.1 ± 16.6P < 0.01
Free androgen index12.3 ± 5.34.5 ± 8.1P < 0.01
Omentin-1 (ng/ml)255.8 ± 78.2348.0 ± 112.6P < 0.05
  • Data are means ± SD. Group comparison by Mann-Whitney U test. FAI = T (nmol/l)/sex hormone–binding globulin (nmol/l) × 100. NS, not significant.